In this issue:
Xanomeline and trospium for schizophrenia
A novel glycine transporter inhibitor improved cognition in schizophrenia
Impact of weight change in antipsychotic-naïve and antipsychotics switch patients
Neurobiology of schizophrenic disorders with or without early cannabis use
Clozapine and mortality
A comparison of depressive symptom profiles between current MDD and SSD
VRT vs CBT for treatment-resistant schizophrenia
Intermittent theta burst stimulation for negative symptoms of schizophrenia
Safety of lumateperone for stable schizophrenia
Ten years of clinical experience with clozapine
Please login below to download this issue (PDF)